Cited by 179Blood Pressure and Hypertension StudiesHeart rate and cardiovascular healthHeart Rate Variability and Autonomic Control

Usefulness of Heart Rate to Predict Cardiac Events in Treated Patients With High-Risk Systemic Hypertension

Open access
Julius, Stevo, Palatini, Paolo, Kjeldsen, Sverre E., Zanchetti, Alberto, Weber, Michael A., McInnes, Gordon T., Brunner, Hans R., Mancia, Giuseppe +7 more·2012·The American Journal of Cardiology

Abstract

A high heart rate (HR) predicts future cardiovascular events. We explored the predictive value of HR in patients with high-risk hypertension and examined whether blood pressure reduction modifies this association. The participants were 15,193 patients with hypertension enrolled in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial and followed up for 5 years. The HR was assessed from electrocardiographic recordings obtained annually throughout the study period. The primary end point was the interval to cardiac events. After adjustment for confounders, the hazard ratio of the composite cardiac primary end point for a 10-beats/min of the baseline HR increment was 1.16 (95% confidence interval 1.12 to 1.20). Compared to the lowest HR quintile, the adjusted hazard ratio in the highest quintile was 1.73 (95% confidence interval 1.46 to 2.04). Compared to the pooled lower quintiles of baseline HR, the annual incidence of primary end point in the top baseline quintile was greater in each of the 5 study years (all p <0.05). The adjusted hazard ratio for the primary end point in the highest in-trial HR heart rate quintile versus the lowest quintile was 1.53 (95% confidence interval 1.26 to 1.85). The incidence of primary end points in the highest in-trial HR group compared to the pooled 4 lower quintiles was 53% greater in patients with well-controlled blood pressure (p <0.001) and 34% greater in those with uncontrolled blood pressure (p = 0.002). In conclusion, an increased HR is a long-term predictor of cardiovascular events in patients with high-risk hypertension. This effect was not modified by good blood pressure control. It is not yet known whether a therapeutic reduction of HR would improve cardiovascular prognosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.amjcard.2011.10.025

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Julius, S., Palatini, P., Kjeldsen, S. E., Zanchetti, A., Weber, M. A., McInnes, G. T., Brunner, H. R., Mancia, G., Schork, M. A., Hua, T. A., Holzhauer, B., Zappe, D., Majahalme, S., Jamerson, K., & Koylan, N.
Affiliations
  • University of Michigan (US)
  • University of Padua (IT)
  • Oslo University Hospital (NO)
  • University of Milan (IT)
  • State University of New York (US)
  • University of Glasgow (GB)
  • University of Lausanne (CH)
  • University of Milano-Bicocca (IT)
  • Istanbul University (TR)
Corresponding author
Julius, Stevo
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
2012-03
Volume
109
Issue
5
Pages
685-692
ISSN
0002-9149 (ISSN-L)
OpenAlex
W2168586084
Cited by
179
References
28
Citations by year
2026: 2 · 2025: 6 · 2024: 5 · 2023: 15 · 2022: 10 · 2021: 10 · 2020: 17 · 2019: 7 · 2018: 9 · 2017: 10 · 2016: 18 · 2015: 5 · 2014: 9 · 2013: 33 · 2012: 23
FWCI
14.25
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
Keywords
heart rate, high-risk hypertension, cardiovascular events, cardiac event prediction, blood pressure control, valsartan, antihypertensive therapy, VALUE trial, cardiovascular prognosis
MeSH terms
Amlodipine, Valsartan Drug Combination, Aged, Antihypertensive Agents, Blood Pressure, Dose-Response Relationship, Drug, Double-Blind Method, Drug Combinations, Electrocardiography, Female, Follow-Up Studies, Heart Rate, Humans, Hypertension, Male, Predictive Value of Tests, Prognosis, Prospective Studies, Risk Factors, Tachycardia, Tetrazoles, Time Factors, Incidence, Survival Rate, Proportional Hazards Models, Treatment Outcome, Amlodipine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review